S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.65 (+1.01%)
AAPL   146.55 (+1.18%)
MSFT   307.29 (+1.01%)
FB   335.34 (+3.26%)
GOOGL   2,855.56 (+1.00%)
TSLA   870.11 (+3.21%)
AMZN   3,446.74 (+1.11%)
NVDA   222.22 (+1.65%)
BABA   166.82 (-0.70%)
NIO   39.61 (+5.04%)
CGC   13.20 (-1.12%)
GE   104.12 (-0.28%)
AMD   116.43 (+3.84%)
MU   67.26 (-0.62%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.14 (-3.01%)
PFE   41.32 (-0.41%)
BA   216.98 (-0.03%)
AMC   43.03 (+5.62%)
NASDAQ:LSAQ

LifeSci Acquisition II Stock Forecast, Price & News

$10.57
-1.20 (-10.20 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.10
▼
$11.99
50-Day Range
$9.01
▼
$12.31
52-Week Range
$8.42
▼
$12.68
Volume118,564 shs
Average Volume53,514 shs
Market Capitalization$105.82 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive LSAQ News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeSci Acquisition II and its competitors with MarketBeat's FREE daily newsletter.


About LifeSci Acquisition II

LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.

Headlines

With SPAC deal done, Triangle science company hits public markets
October 7, 2021 |  finance.yahoo.com
Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
October 7, 2021 |  finance.yahoo.com
October SPAC Merger Calendar: A Look At Upcoming Votes, Stocks To Watch
October 4, 2021 |  markets.businessinsider.com
LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
June 16, 2021 |  finance.yahoo.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of LifeSci Acquisition II Corp. - LSAQ
May 12, 2021 |  finance.yahoo.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. Merger
May 12, 2021 |  finance.yahoo.com
Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B
May 7, 2021 |  finance.yahoo.com
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of LifeSci Acquisition II Corp. (Nasdaq – LSAQ)
May 7, 2021 |  finance.yahoo.com
Science 37 Is Going Public Via LifeSci II SPAC Merger
May 7, 2021 |  bloomberg.com
Instant Unicorn: Triangle science company goes public through SPAC merger
May 7, 2021 |  bizjournals.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LSAQ
Previous Symbol
CUSIP
N/A
CIK
1819113
Web
lifesciacquisition.com
Phone
646-899-1200
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.50 per share
Price / Book
21.14

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.07
Quick Ratio
4.07

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
10,011,000
Market Cap
$105.82 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

0.33 out of 5 stars

Medical Sector

1308th out of 1,361 stocks

Commercial Physical Research Industry

23rd out of 26 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












LifeSci Acquisition II (NASDAQ:LSAQ) Frequently Asked Questions

What stocks does MarketBeat like better than LifeSci Acquisition II?

Wall Street analysts have given LifeSci Acquisition II a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LifeSci Acquisition II wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are LifeSci Acquisition II's key executives?

LifeSci Acquisition II's management team includes the following people:
  • Dr. Andrew Ian McDonald Ph.D., Chairman & CEO (Age 47)
  • Mr. David Dobkin, CFO, Head of Strategy & Director (Age 42)
  • Mr. Michael Yehuda Rice, COO & Director (Age 56)

When did LifeSci Acquisition II IPO?

(LSAQ) raised $75 million in an IPO on Friday, November 20th 2020. The company issued 7,500,000 shares at $10.00 per share. LifeSci Capital and Ladenburg Thalmann served as the underwriters for the IPO.

What is LifeSci Acquisition II's stock symbol?

LifeSci Acquisition II trades on the NASDAQ under the ticker symbol "LSAQ."

How do I buy shares of LifeSci Acquisition II?

Shares of LSAQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeSci Acquisition II's stock price today?

One share of LSAQ stock can currently be purchased for approximately $11.77.

How much money does LifeSci Acquisition II make?

LifeSci Acquisition II has a market capitalization of $117.83 million.

How many employees does LifeSci Acquisition II have?

LifeSci Acquisition II employs 2 workers across the globe.

What is LifeSci Acquisition II's official website?

The official website for LifeSci Acquisition II is lifesciacquisition.com.

How can I contact LifeSci Acquisition II?

The company can be reached via phone at 646-899-1200 or via email at [email protected].


This page was last updated on 10/18/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.